Skip to content
MarketScale
‹ Back to IndustriesSciences

SupplySide West 2021: Market Trends

SupplySide West 2021 serves as a critical platform for companies like Deerland to innovate and stay attuned to market trends. The event enables face-to-face interactions, allowing Deerland to engage directly with customers and industry peers. Deerland aims to expand beyond supplements into food and beverage sectors, leveraging versatile ingredient applications and exploring diverse product formats.

This story was produced through MarketScale. See how Sciences teams put it to work with Executive Thought Leadership.

By Sciences · Diverse Delivery FormatsFood and BeverageHuman-grade IngredientsIndustry Trends.
Share
SupplySide West 2021: Market Trends

Key takeaways

01

SupplySide West provides a platform for innovation and understanding customer needs.

02

Deerland is expanding into food and beverage through versatile ingredient applications.

03

Embracing diverse delivery formats, like gummies and liquids, attracts significant interest.

Get featured

Want to get featured in MarketScale Sciences?

Create a free MarketScale workspace and get your company's expertise featured across our Sciences coverage. No credit card, no demo required.

Start free

Supply Side West holds immense significance for Deerland, providing a platform for innovation and a chance to understand customer needs. This event keeps Deerland in tune with market trends and ensures the development of impactful and sought-after products. The return to in-person interactions at Supply Side West is truly invigorating, allowing Deerland to engage with industry peers and customers face-to-face.

With a focus on food and beverage, Deerland aims to expand its reach beyond the supplement space. The goal is to showcase the versatility of their ingredients, probiotics, and Solarplast in diverse applications. Embracing different delivery formats is a key trend, with gummies and liquid formats gaining significant interest. By exploring new avenues outside traditional capsules, Deerland aims to meet evolving consumer preferences and offer innovative solutions.

The connection between the human and pet industries is becoming increasingly apparent. Consumers seek clean and functional ingredients that enhance the health and well-being of both themselves and their pets. Deerland already produces human-grade ingredients, aligning with the growing demand for quality in the pet industry. As the pet market evolves, new ingredients will play a crucial role. Combining probiotics with prebiotics or phages to create synergistic functional ingredients holds promise for future pet products.

Supply Side West’s incorporation of food ingredients is a welcome development, as it highlights the blending of the food and supplement sectors. Deerland has identified complementary ingredients that can enhance their flagship DE111 probiotic, such as powdered kombucha, powdered kefir, and the growing interest in hemp and botanicals. The opportunities are endless, and Supply Side West offers a diverse and vibrant environment to explore and learn from.

Attending Supply Side West for the first time has provided a fresh perspective for Deerland. Stepping out of their comfort zone and witnessing the broader industry landscape has been both insightful and enjoyable. It’s not only about understanding industry trends but also recognizing the impact that DE111, Deerland’s flagship product, is making in the market.

Deerland remains committed to staying at the forefront of innovation and responding to customer demands. By embracing new ingredients, exploring novel delivery formats, and maintaining a human-grade standard, Deerland aims to drive positive change and contribute to the well-being of people and pets alike.

Your experts belong here

Every story in MarketScale Sciences starts with a company putting its lab directors, applications scientists, and field specialists on the record. Buyers are already reading this topic. The only question is whose experts they find.

Lab and research buyers verify before they trial, and your scientists give them something credible to verify against.

Get your team featuredSee how it works15 minutes, straight to a calendar.

About the author

S
Sciences
B2B Weekly

The week in Sciences, and sixteen other industries, every Monday.

Ten stories, one-line takes, five minutes. Free.

Sciences: are you visible to AI?

Before they reach out, Sciences buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free plan

You just read one Sciences expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your lab directors, applications scientists, and field specialists into the articles, video, and social content Sciences buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale workspace, up to 10 people
One professional video edit a month for qualifying companies
Media requests to your crowd, remote recording, AI writing tools
$0, no credit card, nothing that expires

More Sciences Insights

CDMOs’ new capacity skews stainless by liters, but single-use leads by system count

CDMOs’ new capacity skews stainless by liters, but single-use leads by system count

Contract Pharma reports bioTRAK data projecting CDMOs will install roughly 120 bioreactors by 2030. It says 71% of added volume is large-scale stainless steel, while 61% of systems are single-use.

  • 01Utilization discipline is still driving builds: BioTRAK’s Dawn Ecker told Contract Pharma expansion conversations typically start after a site is booked above ~80% for several years.

Sep 22, 2026

Pharma supplier diversification means little if every supplier uses the same airport

Pharma supplier diversification means little if every supplier uses the same airport

Biocair's Patrick Wohl argues in Pharmaceutical Commerce that life sciences firms must map airports, sea lanes, customs gateways and carriers alongside suppliers. Suppliers spread across countries can still share one air hub. The fix he describes is pre-qualified alternate routes and continuous review, with clinical trial shipments and cold-chain medicines the first cargo exposed when a corridor closes.

  • 01A supplier base spread across several countries can still be a single point of failure if every shipment routes through one airport hub or corridor; the sharper question for a logistics provider is which hubs each qualified lane actually depends on.
  • 02Gartner data cited by MD+DI gives a benchmark: 42% of procurement leaders rank supply disruption as their organization's top risk, with geopolitical issues including tariffs and regulatory changes ranking third.
  • 03A route map ages fast. Pharmaceutical Commerce published the mapping argument on July 24 and was reporting fresh Red Sea and Iran-related freight risk for pharma lanes by Aug. 10, which is the case for treating mapping as a recurring review rather than a project.

Sep 17, 2026

Resilience and Lilly Invest $750 Million to Increase U.S.-Manufactured Medicine Supply

Resilience and Lilly Invest $750 Million to Increase U.S.-Manufactured Medicine Supply

Resilience and Eli Lilly are investing $750 million to expand KwikPen injectable device production at Resilience's Cincinnati-region manufacturing facility, expected to create 400 high-skilled jobs and reach full operations by early 2027. The partnership builds on their collaboration since 2023, which has already produced over 150 million doses of Lilly medications for the U.S. market.

  • 01$750 million investment to expand Resilience's Ohio manufacturing capacity for Eli Lilly's KwikPen injectable device production
  • 02400 new high-skilled jobs expected in Cincinnati region, with full operations by early 2027
  • 03Partnership has already produced over 150 million doses of Lilly medications for the U.S. market since 2023

Sep 14, 2026

Explore More Sciences Insights

Read more expert perspectives from across Sciences.

Browse Sciences Hub

About the Expert

S
Sciences

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Sciences and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512